Trials / Completed
CompletedNCT02093949
Substrate Ablation Guided by High Density Mapping in Atrial Fibrillation
Substrate Ablation Guided by Automatic High Density Mapping for the Treatment of Atrial Fibrillation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 152 (actual)
- Sponsor
- Hospital St. Joseph, Marseille, France · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate a new AF Substrate mapping method based on automatic high density CFAE detection with a multipolar catheter (Pentaray) and the " SCI 30-40 " setting of CARTO CFAE algorithm.
Detailed description
This study is observational : This substrate ablation method is performed routinely in the centers involved in the study so, patients were not assigned by the investigators to undergo a specific procedure because of the study, in all cases patient would have beneficiate from this substrate mapping ablation method. We assessed procedural and follow up outcomes of this subatrate ablation group and compared them with an historical control group undergoing conventional ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Routine substrate ablation without pulmonary vein Isolation | |
| PROCEDURE | Routine conventional ablation with pulmonary vein Isolation |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-12-01
- Completion
- 2016-08-01
- First posted
- 2014-03-21
- Last updated
- 2017-11-06
- Results posted
- 2017-05-03
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02093949. Inclusion in this directory is not an endorsement.